Sun Pharma in a long-term downtrend
In early August, the stock registered a 52-week low at 433, attracting buying interest27-08-2017
27-08-2017
No-near term upsides for Sun Pharma Advanced
Delay in commercialisation of near-term opportunities to hurt SPARC, Sun Pharma26-08-2017
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sudhir Valia & Raksha Valia23-08-2017
'Value bottom not reached in Sun Pharma, Lupin'
Global flows should be seen relative to every other emerging markets, says Sreesankar23-08-2017
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sudhir Valia and Rakesh Valia17-08-2017
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sudhir Valia and Rakesh Valia17-08-2017
Updates
Approval of Scheme of Arrangement among Sun Pharma Medisales Private Limited, Ranbaxy Drugs Limited, Gufic Pharma Limited, Vidyut Investments Limited and the Company and their respective members and creditors from National Company Law Tribunal14-08-2017
Sun Pharma slumps to 4-year low
Shares of Sun Pharma slumped to over 4-year low on Q1 loss. The shares dropped as much as 3.8 per cent to Rs 432.7, their lowest since April 2013. The company posted a surprise loss of Rs 425...14-08-2017
Sun Pharma stares at sharp earnings downgrades
A muted revenue outlook and higher costs will keep margins and earnings under pressure in FY1813-08-2017
Sun Pharma Reports Rs 425 Crore Loss In Q1 As Generics Business Suffers
Mumbai-based Sun Pharma posted a net loss of Rs 425 crore for the April-June quarter compared with a profit of Rs 2,034 crore a year earlier.12-08-2017